These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32682931)

  • 1. Noncellular screening for the discovery of protein-protein interaction modulators.
    Kieffer C; Jourdan JP; Jouanne M; Voisin-Chiret AS
    Drug Discov Today; 2020 Sep; 25(9):1592-1603. PubMed ID: 32682931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
    Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
    Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screen for inhibitors of protein-protein interactions in a reconstituted heat shock protein 70 (Hsp70) complex.
    Taylor IR; Dunyak BM; Komiyama T; Shao H; Ran X; Assimon VA; Kalyanaraman C; Rauch JN; Jacobson MP; Zuiderweg ERP; Gestwicki JE
    J Biol Chem; 2018 Mar; 293(11):4014-4025. PubMed ID: 29414793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening-based approaches to identify small molecules that inhibit protein-protein interactions.
    Choi S; Choi KY
    Expert Opin Drug Discov; 2017 Mar; 12(3):293-303. PubMed ID: 28067063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mammalian two-hybrid system as a powerful tool for high-throughput drug screening.
    Patrício D; Fardilha M
    Drug Discov Today; 2020 Apr; 25(4):764-771. PubMed ID: 32032707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A High-Throughput Screening Strategy to Identify Inhibitors of SSB Protein-Protein Interactions in an Academic Screening Facility.
    Voter AF; Killoran MP; Ananiev GE; Wildman SA; Hoffmann FM; Keck JL
    SLAS Discov; 2018 Jan; 23(1):94-101. PubMed ID: 28570838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrative in silico approach for discovering candidates for drug-targetable protein-protein interactions in interactome data.
    Sugaya N; Ikeda K; Tashiro T; Takeda S; Otomo J; Ishida Y; Shiratori A; Toyoda A; Noguchi H; Takeda T; Kuhara S; Sakaki Y; Iwayanagi T
    BMC Pharmacol; 2007 Aug; 7():10. PubMed ID: 17705877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions.
    Hua Y; Camarco DP; Strock CJ; Johnston PA
    Methods Mol Biol; 2018; 1683():211-227. PubMed ID: 29082495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric Modulators of Protein-Protein Interactions (PPIs).
    Ni D; Liu N; Sheng C
    Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of mammalian two-hybrid technologies for high-throughput drug screening.
    Lievens S; Caligiuri M; Kley N; Tavernier J
    Methods; 2012 Dec; 58(4):335-42. PubMed ID: 22917772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel in vitro protein fragment complementation assay applicable to high-throughput screening in a 1536-well format.
    Hashimoto J; Watanabe T; Seki T; Karasawa S; Izumikawa M; Seki T; Iemura S; Natsume T; Nomura N; Goshima N; Miyawaki A; Takagi M; Shin-Ya K
    J Biomol Screen; 2009 Sep; 14(8):970-9. PubMed ID: 19641222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space.
    Zhang X; Betzi S; Morelli X; Roche P
    Future Med Chem; 2014 Jul; 6(11):1291-307. PubMed ID: 24773599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics.
    Petta I; Lievens S; Libert C; Tavernier J; De Bosscher K
    Mol Ther; 2016 Apr; 24(4):707-18. PubMed ID: 26675501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of in Silico Methods for Design and Development of Drugs Targeting Protein-Protein Interactions.
    Cicaloni V; Trezza A; Pettini F; Spiga O
    Curr Top Med Chem; 2019; 19(7):534-554. PubMed ID: 30836920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.